Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
1,910,829
-
Number of holders
-
24
-
Total 13F shares, excl. options
-
804,036
-
Shares change
-
-83,489
-
Total reported value, excl. options
-
$4,277,487
-
Value change
-
-$449,315
-
Number of buys
-
6
-
Number of sells
-
13
-
Price
-
$5.32
Institutional Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) as of Q3 2025
As of 30 Sep 2025 Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) had 24 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 804,036 shares of stock of the company.
Largest 10 holders included Vivo Capital, LLC, Sofinnova Investments, Inc., Pivotal bioVenture Partners Investment Advisor LLC, TANG CAPITAL MANAGEMENT LLC, Nan Fung Group Holdings Ltd, SAMSARA BIOCAPITAL, LLC, Board of Trustees of The Leland Stanford Junior University, VANGUARD GROUP INC, Pfizer Inc, and RENAISSANCE TECHNOLOGIES LLC.
This table shows 24 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.